Sidra Medicine, a member of Qatar Foundation, has established a gene therapy centre to treat rare genetic diseases such as ...

( MENAFN - EIN Presswire) Empowering advancements in personalised medicine by providing a secure and unified platform for clinical-genomic research across Israel's diverse population.

For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

The study will focus on testing lipid-based nanoparticles that encapsulate ribonucleic acid (RNA) for delivery into cells.

How an entire institution successfully integrated genomics into everyday careOrginally published on Illumina News Center NORTHAMPTON, MA / ACCESS Newswire / January 28, 2025 / Over the last 20 years, ...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

Incorporating genomic testing into the management of cervical cancer allows for the creation of personalized treatment plans ...

The 'Iuliu Hatieganu' University of Medicine and Pharmacy in Cluj-Napoca is a strategic partner in the EUR 85 million ROGEN project, a national initiative for the development of genomic research by ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...